Name | Value |
---|---|
Revenues | 14.9B |
Cost of Revenue | 4.4B |
Gross Profit | 10.5B |
Operating Expense | 5.9B |
Operating I/L | 4.6B |
Other Income/Expense | -1.1B |
Interest Income | 0.1B |
Pretax | 3.4B |
Income Tax Expense | 0.3B |
Net Income/Loss | 3.1B |
Pfizer Inc. is a global biopharmaceutical company that specializes in discovering, developing, manufacturing, and selling a wide range of medicines and vaccines. The company's product portfolio includes treatments for cardiovascular, metabolic, women's health, and various therapeutic areas such as immunotherapies, biologics, and biosimilars. Pfizer also offers sterile injectable and anti-infective medicines, as well as oral COVID-19 treatments. Additionally, the company is involved in contract manufacturing. Pfizer serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, generating revenue through the sale of its pharmaceutical products and vaccines.